Translational Development Acquisition Corp. · NASDAQ:TDAC
AQR Capital Management LLC reported a 8.61% stake in Translational Development Acquisition Corp. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
AQR Capital Management LLC reported a 8.61% stake in Translational Development Acquisition Corp., 1,485,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 8.61%
- Shares
- 1,485,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AQR Capital Management, LLC | 8.61% | 1,485,000 |
| AQR Capital Management Holdings, LLC | 8.61% | 1,485,000 |
| AQR Arbitrage, LLC | 8.61% | 1,485,000 |
Source
Related
- Translational Development Acquisition Corp.
- AQR Capital Management LLC
- Translational Development Acquisition Corp. shareholders
- Schedule 13G/A · AQR Capital Management LLC · May 14, 2025
- Schedule 13G/A · Linden Advisors LP · Aug 14, 2026
- Schedule 13G · Meteora Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2026
- Schedule 13G/A · Wolverine Asset Management LLC · Jul 16, 2026
- Schedule 13G · Linden Advisors LP · Jun 2, 2026